the aid library

LIST OPTIONS

Filter

3078

EQUINET Information sheet on COVID-19

R Loewenson EQUINET (2020) C1

Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020. This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level... more

Download (306)

View PDF (372)

South-East Asia regional strategy for primary health care: 2022-2030

World Health Organization WHO (2021) C_WHO

This South-East Asia Regional Strategy for Primary Health Care: 2022-2030 aims to accelerate progress in all countries of the Region towards universal health coverage (UHC), health security and the health-related Sustainable Development Goals (SDGs). It is intended to provide Member States with guid... more

Download (279)

View PDF (178)

Good Pharmacy Practice (GPP) in developing countries

International Pharmaceutical Federation (1997) CC

Recommendations for step-wise implementation

Download (184)

View PDF (206)

Towards transformative integration of the HIV and AIDS response into universal health coverage: Building on the strengths and successes of the HIV and AIDS response

G. Ooms; K. Kruja; M. Hart; D. Ruiz Aidsfonds; PITCH (Partnership to Inspire, Transform and Connect the HIV response) (2019) C2

Experiences from Indonesia, Kenya, Uganda and Ukraine

Download (117)

View PDF (320)

The reality of managing asthma in sub-Saharan Africa – Priorities and strategies for improving care

Mortimer, K.; Masekela, R.; Ozoh, O.; et al. (2022) CC2

Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (163)

View PDF (163)

Interim Infection Prevention and Control Recommendations for Coronavirus Disease 2019 (COVID-19) in Health Care Settings

Ministry of Health, Kenya (2020) C2

Accessed: 02.05.2020 These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu... more

Download (184)

View PDF (194)

IOM Somalia Preparedness and Response Plan - COVID-19

OCHA; Reliefweb; IOM UN Migration IOM Somalia OCHA; Reliefweb; IOM UN Migration IOM Somalia (2020) C2

April 2020

Download (645)

View PDF (832)

First Ethiopian National Population Based Tuberculosis Prevalence Survey

Ministry of Health and Ethiopian Health and Nutrition Research Institute, Federal Democratic Republic of Ethiopia (2011) C1

Download (294)

View PDF (425)

Plausible role for CHW peer support groups in increasing care-seeking in an integrated community case management project in Rwanda: a mixed methods evaluation

Langston, A., Weiss, J., Landegger, J., et al. Global Health: Science and Practice (2014) CC

The Kabeho Mwana project (2006–2011) supported the Rwanda Ministry of Health (MOH) in scaling up integrated community case management (iCCM) of childhood illness in 6 of Rwanda’s 30 districts. The project trained and equipped community health workers (CHWs) according to national guidelines. In p... more

Download (2137)

View PDF (1143)

Information and Communications Technology Response to the Liberia Ebola Crisis

USAID; Net Hope; GBI (2014)

Desk Review and Recommendations for Private Sector Engagement

Download (164)

View PDF (168)

FACTI Panel Interim Report

The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) (2020) CC

The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) was convened by the 74th President of United Nations General Assembly and the 75th President of the Economic and Social Council on 2 March 2020. The objective of the... more

Download (168)

View PDF (196)

Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for key populations

C. Beyrer; A. Kamarulzaman; E. Aaraj; et al. World Health Organization WHO (2016) CC

2016 Update Key population

External Link

WHO guideline on control and elimination of human schistosomiasis
recommended

World Health Organization WHO (2022) CC

Schistosomiasis is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America. It is one of the neglected tropical diseases (NTDs) - a group of diseases and conditions that affect particularly low-income populations, worldwide. Last year, WHO laun... more

Download (170)

View PDF (200)

Promoting the health of refugees and migrants: experiences from around the world

World Health Organization (WHO) (2023) C_WHO

This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.

Download (271)

View PDF (272)

People's charter for health

People's Health Movement People's Health Assembly (2012) C1

The People’s Charter for Health is a statement of the shared vision, goals, principles and calls for action that unite all the members of the PHM coalition. It is most widely endorsed consensus document on health since the Alma Ata Declaration Available in different languages

Download (146)

View PDF (183)

Humanitarian Action for Children 2022 - Kenya

UN Children's Fund UNICEF (2021) C_UNICEF

Download (355)

View PDF (205)

WHO Emergency Response Framework - Internal WHO procedures - Second Edition

World Health Organization WHO (2024) C_WHO

The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a... more

Download (25444)

View PDF (6508)

Ethiopia: Standard Treatment Guidelines for Health Center

Drug Administration and Control Authority of Ethiopia Contents (2014) C1

3rd edition

Download (1391)

View PDF (3513)

Desk-guide for diagnosis and management of TB in children - Africa Edition

Graham, S.M.et al. International Union Against Tuberculosis and Lung Disease (2016) C1

3rd edition

WHO guideline on control and elimination of human schistosomiasis recommended

WHO guideline on control and elimination of human schistosomiasis
recommended